U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Ampio Pharmaceuticals, Inc. (AMPE)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.600.00 (0.00%)
At close: 4:00PM EDT

0.60 +0.02 (3.43%)
After hours: 4:00PM EDT

People also watch
ANTHACRXALIMMRNSGALE
Full screen
Previous Close0.60
Open0.60
Bid0.58 x 400
Ask0.62 x 900
Day's Range0.58 - 0.60
52 Week Range0.38 - 1.14
Volume139,505
Avg. Volume418,753
Market Cap40.94M
Beta0.61
PE Ratio (TTM)-2.90
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals6 months ago

    Colorado biotech's accountants express 'substantial doubt' about firm's future

    In a recent 10-K filing with the Securities and Exchange Commission, Douglas County-based Ampio (AMPE) said "a 'going concern' opinion could impair our ability to finance our operations through the sale of debt or equity securities or through bank financing. Ampio is developing Ampion, an anti-inflammatory drug designed to treat to severe pain associated with osteoarthritis of the knee , which company officials are excited about. In the history of the company, we have never been as close to realizing what we believe to be the full potential of Ampion, both from a regulatory perspective as well as commercial," said Michael Macaluso, chairman, and CEO, in a statement .

  • We're sorry this is all we were able to find about this topic.